This yeas edition took place on August 29 and 30 in Odense. The conference featured two days focused on the smartest approaches to prioritization in cancer research and treatment.
The landscape of cancer research and treatment is in a state of constant evolution, with new technologies and therapies rapidly reshaping the options available to us and the care we extend to our patients. Amidst this dynamic environment, it becomes increasingly clear that setting priorities is essential. Yet, the question remains: what should these priorities be, and how can we allocate our resources wisely?
These crucial deliberations took center stage as DCCC and DMCG.dk extended a warm invitation to clinicians, researchers, patient associations, and decision-makers within the cancer community to join us at Denmark's premier cancer research conference. Participants embarked on a carefully designed journey, guided by distinguished professionals and thought leaders from leading hospitals and universities across Denmark.
Abstract, poster walks and presentation on the main scene
Every year, more than 100 researchers have the opportunity to present their research at the Danish Cancer Research Days. It is a unique opportunity to spread knowledge across geography as well as research area.
From the submitted abstracts, our interdisciplinary committee selected the researchers, who had the opportunity to transform their abstract into a physical poster. The posters were displayed on both conference days and during the poster session. Similar to the previous year, the poster session toke place as moderated poster-walks with discussion groups.
Furthermore, the abstracts were used to nominate seven young scientists for the honerable "Exceptional Young Scientist Abstract"-prize. These seven scientists presented their findings on the main scene.
Program and abstract book
Explore the highlights of this year’s Danish Cancer Research Days. Go to the program and download the abstract book for an in-depth look at the expert-led discussions on advancing cancer research and prioritizing treatment approaches.